MORE PRICE FIXING IN THE GENERIC DRUG INDUSTRY

After the Connecticut matter was filed (see “Girls Night Out), the lawsuit was expanded. In June of 2018 the states filed a lawsuit in Pennsylvania against another dozen manufacturers, including Mylan, Novartis, and Teva, for price fixing involving more than 16 generic drugs.  Five of the drugs are used to treat cardiac conditions, and the others treat a variety of medical issues ranging from depression to multiple sclerosis.


The price fixing included conversations and meetings at various industry conferences and association dinners.  This case was pending in Pennsylvania federal court at the end of Swanson’s tenure. 


image8